MYLAN 1730 MYLAN 1730 (Ursodiol 300 mg)
Pill with imprint MYLAN 1730 MYLAN 1730 is Peach & White, Capsule-shape and has been identified as Ursodiol 300 mg. It is supplied by Mylan Pharmaceuticals Inc..
Ursodiol is used in the treatment of primary biliary cholangitis ; nonalcoholic fatty liver disease; gallbladder disease and belongs to the drug class gallstone solubilizing agents. There is no proven risk in humans during pregnancy. Ursodiol 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 1730 MYLAN 1730
Ursodiol
- Imprint:
- MYLAN 1730 MYLAN 1730
- Strength:
- 300 mg
- Color:
- Peach & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Gallstone solubilizing agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients:
- silicon dioxide
corn starch
FD&C Yellow No. 6
gelatin
hydroxypropyl cellulose
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
sodium starch glycolate type A potato
titanium dioxide
ferrosoferric oxide
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
propylene glycol
shellac
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 51079-0383 | UDL Laboratories Inc. |
More about ursodiol
- Ursodiol Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 14 Reviews
- Drug class: gallstone solubilizing agents
Consumer resources
Other brands: Actigall, Urso, Urso Forte
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
